|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 449.95 DKK | +1.98% |
|
+2.65% | -27.92% |
| 06:51pm | Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs | MT |
| 06:51pm | Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs | MT |
EPS & Dividend: Novo Nordisk A/S
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 4.55 | 5.2 | 6.2 | 9.4 | 11.4 | 13.19 | 15.36 | 17.06 |
| Rate of return | 2.13% | 1.41% | 1.32% | 1.35% | 1.83% | 2.99% | 3.48% | 3.87% |
| EPS 2 | 9.005 | 10.37 | 12.22 | 18.62 | 22.63 | 26.08 | 30.79 | 34.66 |
| Distribution rate | 50.5% | 50.1% | 50.7% | 50.5% | 50.4% | 50.6% | 49.9% | 49.2% |
| Reference price 2 | 213.32 | 367.50 | 469.00 | 698.10 | 624.20 | 441.20 | 441.20 | 441.20 |
| Nbr of stocks (in thousands) | 4,624,923 | 4,557,801 | 4,517,704 | 4,458,288 | 4,441,340 | 4,439,053 | - | - |
| Announcement Date | 03/02/21 | 02/02/22 | 01/02/23 | 31/01/24 | 05/02/25 | - | - | - |
1DKK in Million2DKK
Estimates
Past dividends: Novo Nordisk A/S
| 27/03/2025 | Final Payment 7.9 DKK |
| 14/08/2024 | Interim Payment 3.5 DKK |
| 21/03/2024 | Final Payment 6.4 DKK |
| 17/08/2023 | Interim Payment 6 DKK |
| 23/03/2023 | Final Payment 8.15 DKK |
| 11/08/2022 | Interim Payment 4.25 DKK |
| 24/03/2022 | Final Payment 6.9 DKK |
| 15/08/2021 | Interim Payment 3.5 DKK |
| 25/03/2021 | Final Payment 5.85 DKK |
| 13/08/2020 | Interim Payment 3.25 DKK |
| 26/03/2020 | Final Payment 5.35 DKK |
| 15/08/2019 | Interim Payment 3 DKK |
| 21/03/2019 | Final Payment 5.15 DKK |
| 16/08/2018 | Interim Payment 3 DKK |
| 22/03/2018 | Final Payment 4.85 DKK |
| 17/08/2017 | Interim Payment 3 DKK |
| 23/03/2017 | Final Payment 4.6 DKK |
| 11/08/2016 | Interim Payment 3 DKK |
| 20/03/2016 | Annual 6.4 DKK |
Upcoming events: Novo Nordisk A/S
More events
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
| 2.99% | 3.48% | 16.9x | 9.74x | 6.1x | ||
| 0.77% | 0.85% | 36.38x | 26.24x | 12.05x | ||
| 3.37% | 3.46% | 14.87x | 5.05x | 4.14x | ||
| 3.5% | 3.66% | 26.47x | 45.99x | 6.45x | ||
| 3.84% | 3.93% | 14.1x | 5.31x | 3.46x | ||
| 3.26% | 3.43% | 17.49x | 5.18x | 4.7x | ||
| 2.3% | 2.42% | 21.9x | 4.8x | 4.11x | ||
| 3.98% | 4.18% | 10.36x | 3.68x | 3.36x | ||
| 3.27% | 3.44% | 22.28x | 17.44x | 5.74x | ||
| 6.77% | 6.91% | 11.94x | 1.58x | 2.91x | ||
| Average | 3.4% | 3.58% | 19.27x | 12.50x | 5.30x | |
| Weighted average by Cap. | 2.88% | 3.05% | 22.11x | 15.62x | 6.44x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition